Awarded to
- Awarded value
- €2,961,239
- Award date
- Bid received
- 1 A single tender
- Record with this buyer
- 1 first contract from this buyer in the register
- Back on the market
- Aug 2028 How we know
When this contract comes back
estimated from the stated durationThis contract runs about 24 months, so it is back on the market around August 2028.
Every contract expiring, on the radarSummary
Machine-generated summaryThe Maria Sklodowska-Curie National Oncology Institute - State Research Institute, Gliwice Branch, purchased successive deliveries of the medicine Tisagenlecleucel under task no. 5. The contract was awarded to Novartis Poland Sp. z o.o. on 2026-08-18 through a negotiated procedure with a single invited contractor. The value awarded was about EUR 2,961,238.51, converted from PLN at the ECB reference rate; the official notice states the amount in PLN. Deliveries are to be made successively over 24 months, ending by 2028-08-17, or earlier if the buyer's financial limit is exhausted. After that, the contract comes back to the market.
Description
Terms of the procedure
- How tenders are scored
- Price
As the official notice states them.
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Report an error in this notice
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 2 days ago
What this buyer has paid before
Based on 119 comparable contracts this buyer awarded in this sector over the last 4 years.
- This award
- €3.0M
- Median award
- €291,271
- Middle half of past awards
- €83,206 to €1.2M
The award is larger than three in four past awards.
Most recent awards
- Medical materials - Successive deliveries of medical products for the Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch €35,312
- Pharmaceutical products - Successive deliveries of medicines for the Maria Skłodowska-Curie National Oncology Institute, State Research Institute, Gliwice branch €2,971,595
- Chemical reagents - Successive deliveries of antibodies and reagents for cytometric diagnostics and reagents and consumables for the LIAISON XL analyser with lease of a back-up analyser for the Maria Skłodowska-Curie National Oncology Institute, Gliwice branch €473,351
- Produkty farmaceutyczne - Sukcesywne dostawy leków dla Narodowego Instytutu Onkologii im. Marii Skłodowskiej-Curie - Państwowego Instytutu Badawczego Oddziału w Gliwicach - zadanie nr 5: Tisagenlecleucel €2,945,126
Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.
The buyer
Full buyer profileNarodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy Oddział w Gliwicach
- notices in the register
- 503
- awards
- 270
- awarded in total
- €592.9M
Who wins its contracts
Many suppliers- different companies won its awards
- 199
- of the awards went to the three most frequent winners
- 6%
- of its calls state an estimated value
- 22%
Based on 223 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
Competition
- tenders per lot on average (open and restricted procedures)
- 1.5
- of those lots received a single tender
- 68%
- of the awards went to companies based in another country
- 4%
As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.
One dot per award, on the day it was signed, sized by its value. A ring is an award with no published value.
Awards most often to
8 open tenders right now
- Chemical reagents - Successive deliveries of reagents for detecting DNA of 14 HR-HPV types with lease of molecular analysers as a system compatible with the LBC system held, for the National Institute of Oncology, Gliwice Branch 1 day left
- Pharmaceutical products - Successive deliveries of Iwosydenib for the Maria Sklodowska-Curie National Oncology Institute, Gliwice branch 2 days left
- Antiseptic and disinfection products - Successive deliveries of disinfectants to the National Institute of Oncology, Gliwice Branch 3 days left
Market context
- open now in Medical equipment & pharmaceuticals
- 8,191
- median open notice
- €316,024
Who wins in this market
Many suppliersPoland · Medical equipment & pharmaceuticals
- different companies won awards here
- 13,424
- of the awards went to the three most frequent winners
- 4%
- buyers awarded contracts here
- 1,462
Based on 23,003 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
Competition
- tenders per lot on average (open and restricted procedures)
- 1.8
- of those lots received a single tender
- 63%
- of the awards went to companies based in another country
- 2%
- of the tenders came from another country
- 2%
As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.
Similar tenders
Open now
2
days left
€2,926,817
est. value
Awarded before
Never miss a tender like this
978 new notices in Medical equipment & pharmaceuticals in Poland in the last 7 days. Get an email when new ones appear. Free.
Set up my alertOr follow just its CPV code, Pharmaceutical products: an email when new tenders arrive under it, no account needed.